Regis University NU 641
Advanced Clinical
Pharmacology Exam 1, Exam 2,
Exam 3, Midterm & Final
Questions and Answers (2026-
2027) | Complete Study Guide
350+
Verified Answers Exam Ready With Rationales
359 QUESTIONS
DOCUMENT OVERVIEW
This 2026/27 examination package spans 5 modules — Exam 1 , Exam 2 , Exam
3 , Midterm Exam , and Final Exam — totaling 359 verified questions tailored for
Pharmacology preparation. Coverage is weighted toward Exam 3 (140 questions),
with Exam 1 as the smallest section (36 questions). Every item ships with detailed
rationales explaining the underlying principle, verified correct answers, and supporting
visuals. Best used as a structured review across these sections, or as targeted
remediation on any single module. See the Table of Contents below for the full module
breakdown and question ranges.
Page 1
, CONTENTS
01 Exam 1 Q1–Q36
02 Exam 2 Q37–Q91
03 Exam 3 Q92–Q231
04 Midterm Exam Q232–Q271
05 Final Exam Q272–Q359
MODULE 1 OF 5
Exam 1
36 Questions Q1–Q36
Q1 QUESTION 1 OF 359 Exam 1
When should thiazides NOT be used?
CORRECT ANSWER
if creatinine clearance is less than 30-50 ml/min
RATIONALE
Thiazide diuretics lose efficacy at lower glomerular filtration rates because their tubular
secretion mechanism is impaired, necessitating alternative diuretic classes like loop
diuretics when creatinine clearance falls below 30-50 ml/min. This highlights the importance
of renal function in determining diuretic choice.
Page 2
, Q2 QUESTION 2 OF 359 Exam 1
True or False
Thiazide diuretics is a first-line hypertensive agent and will also help to decrease fluid
retention.
CORRECT ANSWER
True
RATIONALE
Thiazide diuretics are recommended as initial therapy for hypertension and promote
natriuresis and diuresis, thereby reducing extracellular fluid volume. This dual action
addresses both blood pressure regulation and fluid overload.
Q3 QUESTION 3 OF 359 Exam 1
Calcium Channel Blockers MOA
CORRECT ANSWER
Cause coronary artery vasodilation
Cause peripheral arterial vasodilation, thus decreasing systemic vascular resistance
Reduce the workload of the heart
Result: decreased myocardial oxygen demand
(Hypertension, dysrhythmias, angina, and Raynaud's)
RATIONALE
Calcium channel blockers inhibit influx of calcium ions into vascular smooth muscle and
myocardial cells, leading to vasodilation and reduced contractility, thereby decreasing
myocardial oxygen demand and blood pressure. This mechanism is key to their therapeutic
effects in hypertension, angina, and dysrhythmias.
Page 3
, Q4 QUESTION 4 OF 359 Exam 1
Examples of CCBs
CORRECT ANSWER
Verapamil, diltiazem, amlodipine, nifedipine
RATIONALE
Calcium channel blockers (CCBs) like verapamil, diltiazem, amlodipine, and nifedipine inhibit
the influx of calcium ions into cardiac and vascular smooth muscle cells, leading to
decreased contractility and vasodilation. The key principle tested is the identification of
major drug classes and their representative examples.
Q5 QUESTION 5 OF 359 Exam 1
Indications for Verapamil
CORRECT ANSWER
essential HTN, angina (chronic stable, unstable), ventricular rate control in
arrhythmia, dysrhythmias.
RATIONALE
Verapamil, a non-dihydropyridine calcium channel blocker, exerts its therapeutic effects by
slowing sinoatrial and atrioventricular nodal conduction and decreasing myocardial
contractility, making it effective for hypertension, angina, and rate control in supraventricular
arrhythmias. The key concept tested is the pharmacologic mechanism of action of non-
dihydropyridine calcium channel blockers and their resulting clinical applications.
Page 4